Atlas Trials

Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension

Clinical trial NCT02060721 · COMPLETED

Trial details

NCT number
NCT02060721
Sponsor
Actelion
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Thromboembolic Pulmonary Hypertension
Start date
2015-02-03
Primary completion
2022-03-21
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.